首页> 美国卫生研究院文献>Neuro-Oncology >SCDT-15. DRUG-LOADED AND EGFR-TARGETED NANO-CONSTRUCTS SUCCESSFULLY TREAT INTRACRANIAL GLIOMA IN MOUSE MODELS
【2h】

SCDT-15. DRUG-LOADED AND EGFR-TARGETED NANO-CONSTRUCTS SUCCESSFULLY TREAT INTRACRANIAL GLIOMA IN MOUSE MODELS

机译:SCDT-15。在小鼠模型中成功加载药物并靶向EGFR的纳米结构成功治疗颅内胶质瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have developed a peptidyl-targeted nanovector system, the nanosyringe, capable of transferring large amounts of hydrophobic dyes/drugs into cells bearing a targeted surface epitope, in vitro and in vivo. The nanovector is made from a hydrophobic, oxidized graphene core, with polyethylene glycol (PEG) tendrils attached via amide bonds. This untargeted nanovector is both water soluble and has a large internal volume that can be filled with hydrophobic drugs/dyes. Targeting the nanovectors toward specific epitopes is achieved by covalently linking targeting peptides to the PEG terminals, using peptides selected from phage-display libraries. The nanosyringe interior is readily loaded with hydrophobic drugs/dyes and when the GE11 peptide is attached, these nanosyringes are taken up by EGFR-expressing cells along with the nanosyringe payload. In our in vitro and in vivo studies we demonstrate that binding of nanosyringe activates EGFR, which in turn initiates binding/internalization and transfer of payload into the cells. Nanosyringe binding to EGFR causes activation of the clathrin coated-pit endosomal pathway, internalizing the nanosyringes within endosomes. When drugs such as doxorubicin are loaded into nanosyringes, we observe initial transfer into cellular plasma/endosomal membranes, followed by diffusion into the cytosol, then into DNA.In intracranial mouse models of glioma, when drugs are loaded into EGFR-targeted nanosyringes, we observe both enhanced efficacy of chemotherapeutics and lower off-target toxicity.In GBM, highly effective chemotherapeutics such as Vinblastine and Doxorubicin are seldom used clinically because of their off-target toxicity. When comparing native and nanosyringe-loaded chemotherapy in an aggressive intracranial glioma mouse model we observe a huge enhancement (>7-fold) in animal survival, and far lower off-target toxicity. 38% of vinblastine and 50% of doxorubicin treated animals out survived the empty vector controls by more than a year.
机译:我们已经开发出了以肽基为目标的纳米载体系统,即纳米注射器,该系统能够在体外和体内将大量疏水性染料/药物转移到带有目标表面表位的细胞中。纳米载体是由疏水的氧化石墨烯核制成,具有通过酰胺键连接的聚乙二醇(PEG)卷须。这种非靶向的纳米载体既可溶于水,又具有较大的内部体积,可以填充疏水性药物/染料。通过使用选自噬菌体展示文库的肽将靶向肽共价连接至PEG末端,实现了将纳米载​​体靶向特定表位。纳米注射器内部容易装载疏水性药物/染料,当连接GE11肽时,这些纳米注射器被EGFR表达细胞和纳米注射器有效载荷吸收。在我们的体外和体内研究中,我们证明了纳米注射器的结合可激活EGFR,进而启动结合/内在化,并将有效载荷转移到细胞中。纳米注射器与EGFR结合会导致网格蛋白包被的凹核内体途径活化,从而使内体中的纳米注射器内化。当将阿霉素等药物加载到纳米注射器中时,我们观察到最初转移到细胞质/内膜中,然后扩散到细胞溶质中,然后扩散到DNA中。在脑胶质瘤的颅内小鼠模型中,当药物加载到EGFR靶向的纳米注射器中时,我们在GBM中,临床上很少使用高效的化学治疗药物,例如长春碱和阿霉素,因为它们具有脱靶毒性。在侵略性颅内神经胶质瘤小鼠模型中比较天然和纳米注射器加载的化学疗法时,我们观察到动物存活率大幅提高(> 7倍),并且脱靶毒性低得多。 38%的长春碱和50%的阿霉素处理过的动物在空载体对照中存活了一年以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号